Moxifloxacin HCl
Pharmaceutical Premium
Pharmaceutical API

Moxifloxacin HCl

High-purity pharmaceutical grade Moxifloxacin HCl manufactured to meet stringent USP/EP specifications for pharmaceutical formulations and research applications. Our pharmaceutical grade material delivers exceptional purity and consistency for critical pharmaceutical manufacturing.

  • USP/EP Grade Specifications
  • High Purity (≥99.0%)
  • Comprehensive Analytical Testing
  • Regulatory Compliance Documentation
  • Pharmaceutical Manufacturing Grade
  • Quality Assurance Certified
Request Quote Technical Support

Technical Specifications

Chemical Formula: C21H24FN3O4·HCl
CAS Number: 186826-86-8
EINECS Number: Not available
Molecular Weight: 437.89 g/mol
Physical State: Pale yellow crystalline powder
Purity (HPLC): ≥99.0% (USP/EP Grade)
Melting Point: 250-255°C (decomposition)
pH (1% solution): 3.9-5.5
Loss on Drying: ≤0.5%
Residue on Ignition: ≤0.1%
Heavy Metals (as Pb): ≤10 ppm
Related Substances: ≤1.0% (total impurities)
Storage Conditions: Store below 25°C, protect from light
Shelf Life: 3 years from date of manufacture
Packaging Options: 25kg drums, 100kg containers

Applications

Bacterial Infections
Broad-Spectrum Antibiotic
Respiratory Infections
Ophthalmic Infections
Antimicrobial Research
Hospital Formulations
Pharmaceutical Manufacturing
DNA Gyrase Inhibitor
Infectious Disease Research
Clinical Trials
Regulatory Submissions
Reference Standards

Industry-Specific Grades

DRAVYOM offers specialized Moxifloxacin HCl grades tailored for specific antibiotic pharmaceutical requirements, ensuring optimal performance and regulatory compliance across diverse antimicrobial therapy applications.

USP Grade (United States Pharmacopeia)
Purity: ≥99.0% (HPLC) Loss on Drying: ≤0.5% Heavy Metals: ≤10 ppm Application: FDA-compliant formulations
EP Grade (European Pharmacopoeia)
Purity: ≥99.0% (HPLC) pH Range: 3.9-5.5 Related Substances: ≤1.0% Application: EU regulatory submissions
Antimicrobial Research Grade
Purity: ≥99.5% (HPLC) Enhanced bioavailability Low endotoxin levels Application: Infectious disease research
Reference Standard Grade
Purity: ≥99.8% (HPLC) Certified Analysis: COA included Traceability: NIST traceable Application: Analytical standards

Quality Standards

DRAVYOM's Moxifloxacin HCl API is manufactured under stringent quality control protocols, meeting international pharmaceutical standards including USP, EP, and cGMP specifications. Our pharmaceutical-grade production ensures consistent performance and regulatory compliance.

cGMP Certified Manufacturing
USP/EP Grade Specifications
≥99.0% HPLC Purity
Advanced Analytical Testing
Light-Protected Processing
Batch-to-Batch Consistency
Comprehensive Certificate of Analysis
Temperature-Controlled Logistics

Advanced Chemical Properties & Performance

Pharmaceutical Grade Moxifloxacin HCl exhibits exceptional chemical properties essential for antimicrobial applications. Its broad-spectrum fluoroquinolone structure and superior stability characteristics ensure reliable performance in demanding antibiotic formulations.

Molecular Properties
Molecular Weight: 437.89 g/mol (as HCl)
Molecular Formula: C21H24FN3O4·HCl
LogP (Octanol/Water): 2.03
Solubility (Water): Soluble (as HCl salt)
Physical Properties
Melting Point: 250-254°C (with decomposition)
Appearance: Yellow to yellowish crystalline powder
pH (1% solution): 3.9-5.5
Bulk Density: 0.50-0.60 g/cm³
Pharmaceutical Properties
Bioavailability: ~90%
Protein Binding: 30-50%
Half-life: 11-14 hours
Mechanism: DNA gyrase and topoisomerase IV inhibition
Quality Specifications
Purity (HPLC): ≥99.0%
Loss on Drying: ≤0.5%
Related Substances: ≤1.0%
Heavy Metals: ≤10 ppm
Stability Properties
Shelf Life: 3 years (unopened)
Storage Temperature: 15-25°C
Light Sensitivity: Store in light-resistant containers
Moisture Sensitivity: Store in dry conditions

Performance Characteristics

Detailed performance metrics demonstrate Moxifloxacin HCl superiority in antimicrobial applications with exceptional broad-spectrum activity, tissue penetration, and therapeutic efficacy across diverse bacterial infection treatment protocols.

Broad-Spectrum Activity

Effective against Gram-positive and Gram-negative bacteria

Enhanced antimicrobial coverage
DNA Gyrase Inhibition

Potent bacterial DNA replication inhibition

Rapid bactericidal action
Respiratory Penetration

Excellent lung tissue concentration

Superior respiratory infection treatment
Extended Half-life

11-14 hour elimination half-life

Once-daily dosing convenience
Clinical Efficacy

Proven efficacy in respiratory infections

FDA-approved therapeutic performance
Resistance Profile

Low resistance development potential

Sustained antimicrobial effectiveness

Safety Information

Pharmaceutical active ingredient requiring careful handling protocols. Handle in controlled environments with appropriate ventilation systems. Use proper personal protective equipment and follow established safety protocols for antimicrobial compounds.

Photosensitivity Risk
Controlled Handling Required
Specialized PPE Required

Storage & Handling

Store in tightly closed, light-resistant containers in a cool, dry place away from direct sunlight. Maintain controlled room temperature storage and ensure protection from moisture and humidity to preserve pharmaceutical quality and antimicrobial potency.

Controlled room temperature (15-25°C)
Protect from light (photosensitive)
Light-resistant containers mandatory
Store in dry conditions

Chemical Mechanisms & Reaction Pathways

Moxifloxacin HCl demonstrates potent antimicrobial activity through precise DNA gyrase and topoisomerase IV inhibition, providing broad-spectrum therapeutic efficacy with optimized pharmacokinetic profiles for enhanced bioavailability.

DNA Gyrase Inhibition

Selective binding to DNA gyrase-DNA complex prevents supercoiling

Bactericidal mechanism for broad-spectrum activity
Topoisomerase IV Targeting

Dual enzyme inhibition enhances antimicrobial potency

Reduces resistance development potential
Cellular Uptake

Optimized molecular structure for enhanced tissue penetration

Superior bioavailability and distribution
Pharmacokinetic Profile

Extended half-life with minimal renal elimination

Once-daily dosing convenience

Regulatory Compliance & Documentation

Comprehensive regulatory compliance ensures global pharmaceutical acceptance with complete documentation packages supporting international drug development and manufacturing requirements.

USP Specifications

United States Pharmacopeia pharmaceutical grade compliance

EP Standards

European Pharmacopoeia specifications and testing protocols

ICH Guidelines

International harmonized pharmaceutical development standards

Global Regulatory

Multi-regional pharmaceutical registration support

DMF Support

Drug Master File preparation and regulatory submission

GMP Compliance

Good Manufacturing Practice certified production

Technical Support & Value-Added Services

DRAVYOM's pharmaceutical development team provides comprehensive formulation support, analytical method development, and regulatory assistance to optimize Moxifloxacin HCl performance in pharmaceutical applications.

Formulation Development
  • Stability enhancement strategies
  • Bioavailability optimization
  • Excipient compatibility studies
  • Dosage form development
Analytical Services
  • Method validation and transfer
  • Impurity profiling and identification
  • Stability testing programs
  • Dissolution testing support
Regulatory Support
  • Regulatory strategy development
  • Documentation preparation
  • Regulatory submission support
  • Global compliance guidance
Supply Solutions
  • Reliable supply chain management
  • Flexible packaging options
  • Emergency supply arrangements
  • Global distribution network

Environmental Impact & Sustainability

Our Moxifloxacin HCl production emphasizes environmental responsibility through sustainable pharmaceutical manufacturing practices, waste minimization, and comprehensive environmental impact management.

Green Chemistry

Environmentally conscious synthesis with minimal waste

Water Management

Advanced wastewater treatment and recycling systems

Energy Efficiency

Optimized manufacturing processes with reduced energy consumption

Waste Reduction

Comprehensive waste minimization and disposal protocols

ISO 14001

Environmental management system certified production

Carbon Footprint

Reduced environmental impact through sustainable practices

Manufacturing Excellence & Quality Control

DRAVYOM's state-of-the-art pharmaceutical manufacturing facility employs advanced synthesis technology and continuous monitoring systems to ensure consistent Moxifloxacin HCl quality and performance across all production batches.

GMP Production

Good Manufacturing Practice certified facility with controlled environments

Pharmaceutical-grade production standards
Quality Testing

Comprehensive analytical testing including impurity profiling and stability

HPLC, LC-MS, and pharmacopeial methods
Quality Systems

ISO 9001:2015 quality management with pharmaceutical compliance

Continuous improvement and validation protocols
Packaging Control

Controlled atmosphere packaging with stability maintenance

Moisture and light protection systems

Market Applications & Performance Data

Comprehensive pharmaceutical data demonstrating Moxifloxacin HCl effectiveness across diverse therapeutic applications with quantified performance metrics and clinical validation.

Pharmaceutical Manufacturing
Bioavailability: >90% oral absorption Stability: 36+ months shelf life Purity: >99.5% pharmaceutical grade
Drug Development
Formulation Support: 100+ successful formulations Regulatory Success: Global approvals achieved Innovation: Custom synthesis capabilities
Clinical Applications
Efficacy: Broad-spectrum antimicrobial activity Safety: Established clinical profile Convenience: Once-daily dosing regimen

DRAVYOM Competitive Advantages

Pharmaceutical Excellence

Consistently exceeds USP/EP specifications with pharmaceutical-grade quality and performance

Reliable Supply

Guaranteed availability with strategic inventory management and pharmaceutical-grade production

Development Expertise

Dedicated pharmaceutical team provides formulation development and regulatory support

Quality Assurance

Comprehensive documentation with pharmaceutical-grade certificates and regulatory compliance

Global Standards

International compliance with USP, EP, and ICH guidelines for worldwide acceptance

Partnership Approach

Collaborative relationships with pharmaceutical companies and custom development services